Global Budesonide (BUD) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Budesonide (BUD) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Budesonide (BUD) market size was valued at USD 8440.5 million in 2023 and is forecast to a readjusted size of USD 12160 million by 2030 with a CAGR of 5.4% during review period.

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.

The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.

The Global Info Research report includes an overview of the development of the Budesonide (BUD) industry chain, the market status of Respiratory Disease Treatment (Nasal Spray, Inhaler), Nose Disease Treatment (Nasal Spray, Inhaler), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Budesonide (BUD).

Regionally, the report analyzes the Budesonide (BUD) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Budesonide (BUD) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Budesonide (BUD) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Budesonide (BUD) industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Nasal Spray, Inhaler).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Budesonide (BUD) market.

Regional Analysis: The report involves examining the Budesonide (BUD) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Budesonide (BUD) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Budesonide (BUD):

Company Analysis: Report covers individual Budesonide (BUD) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Budesonide (BUD) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Respiratory Disease Treatment, Nose Disease Treatment).

Technology Analysis: Report covers specific technologies relevant to Budesonide (BUD). It assesses the current state, advancements, and potential future developments in Budesonide (BUD) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Budesonide (BUD) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Budesonide (BUD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Nasal Spray
Inhaler
Pill

Market segment by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment

Major players covered
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici
Orion
Cipla
Synmosa Biopharma
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Budesonide (BUD) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Budesonide (BUD), with price, sales, revenue and global market share of Budesonide (BUD) from 2019 to 2024.

Chapter 3, the Budesonide (BUD) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Budesonide (BUD) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Budesonide (BUD) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Budesonide (BUD).

Chapter 14 and 15, to describe Budesonide (BUD) sales channel, distributors, customers, research findings and conclusion.